| [1] |
DU Xueyang, NIU Fanqi, DONG Xiaoping, YANG Pengfei, ZHOU Wenli, WANG Sinong.
Mechanism of Sanhuang Gel regulating TLRs/NLRP3 signaling pathway to improve acne model in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(6): 741-749.
|
| [2] |
DING Ding, WU Shengnan, WANG Ancai, WANG Deguo.
Research progress on the inhibition of cardiac remodeling by vericiguat
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(6): 858-863.
|
| [3] |
CHENG Weigang, LI Haolin, YANG Juanjuan, BAI Qian, JING Luoyang, HU Lele, JIN Fangmei, WANG Haidong.
Qingre sanzhuo decoction treats hyperuricemia complicated with gouty arthritis via TLR4/Myd88/NF-κB signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(4): 456-463.
|
| [4] |
GAO Wanli, ZHOU Qichun, WANG Sumei.
Fructus Akebiae induces apoptosis via regulating ROS-mediated PI3K-Akt signaling pathway in non-small cell lung cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(3): 339-346.
|
| [5] |
LIU Zihan, DU Wenyu, GUO Caihui, WANG Zhi, LI Ying, DONG Zhanjun.
Research progress of empagliflozin in the treatment of type 2 diabetes mellitus and cardiovascular and renal benefits
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(3): 412-418.
|
| [6] |
LYU Shichao, WANG Yunjiao, ZUO Yiming, SHANG Hongcai.
Evidence map on the treatment of heart failure with Yiqifumai injection
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(2): 222-231.
|
| [7] |
WANG Jia, WANG Lei, XU Binfa, LIU Feng, WEN Xin, CHEN Min, GAO Yinsi.
Analysis of risk factors for intolerance of valsartan with Sakubatrol in patients with heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(2): 232-237.
|
| [8] |
HE Hui, GUO Mingliang, RAN Licheng, WANG Yajun.
Research progress on the effect of hippocampal FXR regulation of CREB-BDNF signaling pathway on depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(2): 265-271.
|
| [9] |
SONG Xiaoping, LIU Pingping, LIU Xiaolin, ZHENG Yan, SUN Bin, DING Jian, ZHU Yuanqi, LI Junfeng.
Effects of emodin on autophagy and apoptosis in rats with severe pneumonia caused by Klebsiella pneumoniae by regulating SIRT1/AMPK signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(1): 42-50.
|
| [10] |
LI Yanmei, MA Chaochao, NIU Fanqi, YANG Pengfei, WANG Ning, WANG Sinong, LI Tingbao.
Mechanism of Fuyangjing gel in the treatment of chronic eczema via JAK1/STAT5 signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(9): 1011-1018.
|
| [11] |
WU Xiaoxue, YE Yiping, LEI Zhendong, ZHANG Zunjing, CHEN Wenling.
Icariin improves hypertensive renal fibrosis and injury through Cx32-Nox4 signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(8): 870-878.
|
| [12] |
LI Quanyang, HAO Yafang, WU Guotai, WANG Ruiqiong.
Research progress on the regulation of endometriosis by PI3K/Akt signaling pathway and the intervention effect of traditional Chinese medicine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 501-511.
|
| [13] |
SU Beibei, YANG Lixia, LIANG Yonglin, ZHU Xiangdong, YANG Xia, XUE Chunxia, ZHANG Pu, PEI Xiaoli.
Mechanism of Dahuangtang pellets in regulating podocyte autophagy of diabetic nephropathy mice through AMPK/mTOR/ULK1 signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(3): 260-269.
|
| [14] |
WANG Xin, WANG Yifan, SHANG Muhong, LIU Yuyan, CHEN Guangliang.
Di'ao Xinxuekang activates IRS-1/PI3K/Akt signal pathway to improve insulin resistance in nonalcoholic fatty hepatitis mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(2): 121-129.
|
| [15] |
YU Jiling, ZHANG Jing, DENG Yifan, HE Shenghu.
Advances in the study of ω-3 PUFA in heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(2): 236-240.
|